X0202 SCHEDULE 13D/A 0001563786 XXXXXXXX LIVE 2 Common Stock, $0.0001 par value 05/01/2026 false 0001843714 98906V100 Zapata Quantum, Inc.

6 Liberty Square #2488 Boston MA 02109

Lori A. Weber, Esq. 754-315-3147 Nason Yeager Gerson Harris & Fumero P.A. 3001 PGA Blvd Ste 305 Palm Beach Gardens FL 33410 0001563786 N Clark Golestani b PF N X1 36820792.00 0.00 36820792.00 0.00 36820792.00 N 20.9 IN Common Stock, $0.0001 par value Zapata Quantum, Inc. 6 Liberty Square #2488 Boston MA 02109 This Amendment 2 amends the Schedule 13DA filed with the Securities and Exchange Commission on October 23, 2025 and is being filed to reflect the recent voluntary registration by Zapata Quantum, Inc. ("Issuer") of its common stock pursuant to Section 12(g) of the Act to enable the Issuer to become a mandatory "reporting company" subject to the Act. As a mandatory "reporting company" the Issuer is now required to make periodic disclosures including, by filing annual reports on Form 10-K, Quarterly Reports on Form 10-Q and must promptly disclose certain important events on a Form 8-K. The Reporting Person's interest in securities of the Issuer described in Item 5 below has not changed except as related to the additional vesting of previously reported grants and a decrease to the aggregate percentage beneficially owned as calculated based upon the Issuer's outstanding shares as of March 23, 2026. Clark Golestani 6 Liberty Square, #2488, Boston, MA 02109 Mr. Golestani is a director of Zapata Quantum, Inc. During the past five years the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). During the past five years the Reporting Person has not been a party to a civil proceeding or a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. United States On October 9, 2025, the Reporting Person received 1,000,000 stock options, vesting in equal monthly increments over two years, with the first vesting date to occur on November 9, 2025, subject to vesting conditions. The Reporting Person is a director of the Issuer. He acquired all of his securities with the purpose of exercising control. The Reporting Person beneficially owns (i) 32,500,000 restricted shares of the Issuer's Common Stock , vesting in equal monthly installments over a two-year period, (ii) 176,288 additional shares of the Issuer's Common Stock , (iii) 34,279 shares of Common Stock underlying stock options exercisable until February 4, 2031, with an exercise price of $2.02 per share; (iv) 68,558 shares of Common Stock underlying stock options exercisable until July 31, 2033, with an exercise price of $3.80 per share; (v) 2,500,000 shares of Common Stock issuable upon conversion of a convertible promissory note in the principal amount of $100,000 with a conversion price of $0.04 per share, (vi) 1,250,000 shares of Common Stock issuable upon exercise of a five-year warrant to purchase shares of Common Stock with an exercise price of $0.04 per share, and (vii) 291,667 shares of Common Stock underlying stock options, which represent a portion of a grant of 1,000,000 stock options on October 9, 2025 with an exercise price of $0.08 per share, the remainder of which vests in equal monthly increments over two years. The above number of shares amounts to approximately 20.9% of the 172,293,506 outstanding shares of common stock as of March 23, 2026. The Reporting Person has the sole power to vote or to direct the vote, sole power to dispose or to direct the disposition of all shares beneficially owned by the Reporting Person. Except as described in this Schedule 13D under Item 3 above, the Reporting Person did not engage in any transactions in shares of the Company's common stock during the past 60 days. Not applicable. Not applicable. Not applicable. Not applicable. Clark Golestani /s/ Clark Golestani 05/04/2026